Recombinant multi-species NONO protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NONO protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an RNA-binding protein which plays various roles in the nucleus, including transcriptional regulation and RNA splicing. A rearrangement between this gene and the transcription factor E3 gene has been observed in papillary renal cell carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes exist on Chromosomes 2 and 16. [provided by RefSeq, Feb 2009]
The Alternative Names of target: 52 kDa subunit,54 kDa nuclear RNA- and DNA-binding protein (p54(nrb),55 kDa nuclear protein (NMT55),DNA-binding p52/p100 complex,MRXS34,NMT55,NONO,NRB54,Non-POU domain-containing octamer-binding protein,NonO protein,Nono,P54,P54NRB,PPP1R114,nonA,p54nrb)

Target products collectionGo to NONO products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP9119-Ag-1/ GM-Tg-hg-IP9119-Ag-2 Human NONO protein Human
GM-Tg-rg-IP9119-Ag-1/ GM-Tg-rg-IP9119-Ag-2 Rat NONO protein Rat
GM-Tg-mg-IP9119-Ag-1/ GM-Tg-mg-IP9119-Ag-2 Mouse NONO protein Mouse
GM-Tg-cynog-IP9119-Ag-1/ GM-Tg-cynog-IP9119-Ag-2 Cynomolgus/Rhesus macaque NONO protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP9119-Ag-1/ GM-Tg-felg-IP9119-Ag-2 Feline NONO protein Feline
GM-Tg-cang-IP9119-Ag-1/ GM-Tg-cang-IP9119-Ag-2 Canine NONO protein Canine
GM-Tg-bovg-IP9119-Ag-1/ GM-Tg-bovg-IP9119-Ag-2 Bovine NONO protein Bovine
GM-Tg-equg-IP9119-Ag-1/ GM-Tg-equg-IP9119-Ag-2 Equine NONO protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP9119-Ag-1/ GM-Tg-hg-IP9119-Ag-2; GM-Tg-rg-IP9119-Ag-1/ GM-Tg-rg-IP9119-Ag-2;
GM-Tg-mg-IP9119-Ag-1/ GM-Tg-mg-IP9119-Ag-2; GM-Tg-cynog-IP9119-Ag-1/ GM-Tg-cynog-IP9119-Ag-2;
GM-Tg-felg-IP9119-Ag-1/ GM-Tg-felg-IP9119-Ag-2; GM-Tg-cang-IP9119-Ag-1/ GM-Tg-cang-IP9119-Ag-2;
GM-Tg-bovg-IP9119-Ag-1/ GM-Tg-bovg-IP9119-Ag-2; GM-Tg-equg-IP9119-Ag-1/ GM-Tg-equg-IP9119-Ag-2
Products Name NONO protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NONO
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NONO protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.